Telenor seeks clarity on 2G controversy

Telenor owns 67.25 per cent stake in Unitech wireless which offers mobile services under the brand name Uninor.

PTI | May 5, 2011



With its Indian partner coming under the scanner in the 2G spectrum scam, Norway's telecom firm Telenor, a majority partner in Unitech Wireless, on Wednesday sought an early clarity on the controversy.

Telenor owns 67.25 per cent stake in Unitech Wireless and has invested Rs 6,135.63 crore in it. The telecom joint venture offers mobile services under the brand name Uninor.

"Telenor welcomes an early clarity on these issues," it said in a statement.

Uninor and many other telecoms operators as well as the federal government through the Department of Telecommunications (DoT) and the Trai have been named as respondents in public interest petitions filed before the Supreme Court, it said.

Earlier, Norwegian firm Telenor had asked Sanjay Chandra, who is in the CBI custody facing various telecom and licence- related charges, to step down from the post of Chairmanship till he is given a clean chit.

The CBI has named Chandra and Unitech Wireless, prior to the entry of Telenor, in its chargesheet as part of investigations into irregularities in the allocation of 2G spectrum and licences in 2008.

Recently, some differences have also emerged between Telenor and Unitech Wireless over rights issue, which is now in the court and will come for hearing on May 15.

The company holds a pan-India licence to offer mobile telephony services in each of India?s 22 circles.

It has rolled out services in 21 circles but is commercially present in 13 circles across India - UP West (including Uttaranchal), UP East, Bihar (including Jharkhand), Orissa, Tamil Nadu, Karnataka, Kerala, Andhra Pradesh, Maharashtra, Mumbai, West Bengal, Kolkata and Gujarat.
 

Comments

 

Other News

How the mind can help the body heal itself

Why do some people recover from illness against all odds? Can our beliefs, emotions and consciousness influence the body’s ability to heal? Drawing on over three decades of experience in medicine, research and medical innovation, internationally trained ophthalmologist and author Dr Dinesh Verma ex

1,364 anti-cancer formulations to cost less from today

The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has capped trade margins on the Maximum Retail Price (MRP) of 137 anti-cancer drugs. This was based on the recommendations of an Expert Committee constitute

Who checks the books?

I read about the news about the Coimbatore library over coffee this morning. On the face of it, the headline was about a political ‘war’ between the DMK and TVK. But what stayed with me was something much more important than the blame game behind what had transpired. A writer walking through

Development paradox: Falling poverty miracle and an inequality problem

India’s reduction in poverty over the past decade is a development achievement of considerable significance. The World Bank’s April 2026 ‘India Development Update’ estimates that the share of Indians living below the international extreme-poverty line of $3.00 per person per day i

In Arunachal, a river we call mother

In Arunachal Pradesh, the Siang is not just a river. For many of us, especially the Adi people, it is part of our family. Our grandparents fished in it. Children learned to swim in it. Our farms drink from it. When someone says a huge dam will be built on it, we do not hear the word "project".

A new retelling of the Mahabharata delves into key moments

In a time when every decision carries consequences and questions of ambition, power, loyalty, identity and moral choice continue to shape our lives, Dr. Arun Krishnan’s new book, ‘Mahakshana’ (Penguin India) offers a strikingly relevant retelling of the Mahabharata.  

Upcoming Conferences



-->

Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter